Riskpilot← Back to searchSign inGet full accessMin Osteopat JAC ApS
APSActiveCVR 40433287Sports Allé 1Physiotherapy activities · NACE 8695Est. 201913 employees
Revenue 2024
DKK 2,1M
+28% vs 2023
EBITDA margin
29.0%
+113% vs 2023
Equity ratio
48.5%
Financial strength
Net profit 2024
DKK 477K
+129% vs 2023
| Revenue | DKK 2,1M | +28% |
| EBITDA | DKK 610K | +113% |
| Net profit | DKK 477K | +129% |
| Total assets | DKK 1,3M | +32% |
| Equity | DKK 619K | +81% |
| Employees | 13 | — |
Legal name
Min Osteopat JAC ApS
CVR number
40433287
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
9. april 2019
Share capital
DKK 105.000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør
Company purpose
Selskabets formål er at drive virksomhed med handel og service, samt enhver i forbindelse hermed stående virksomhed.
Address
Sports Allé 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 52 | 7 | 100 | 220 | 1.651 | 2.108 |
| Staff expenses | -0 | -20 | -31 | -98 | -1.365 | -1.497 |
| EBITDA | 52 | -12 | 64 | 123 | 286 | 610 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 52 | -12 | 64 | 123 | 286 | 610 |
| Net financials | -1 | -10 | -22 | -8 | -15 | 2 |
| Profit before tax | 51 | -23 | 42 | 115 | 272 | 612 |
| Tax | 12 | 1 | 17 | 27 | 63 | 136 |
| Net profit | 39 | -24 | 25 | 88 | 208 | 477 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total assets | 168 | 157 | 197 | 640 | 966 | 1.276 |
| Equity | 144 | 121 | 146 | 234 | 342 | 619 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 24 | 36 | 51 | 406 | 624 | 657 |
| Total debt | 24 | 36 | 51 | 406 | 624 | 657 |
EBITDA margin
29.0%
This company
15.8%
Market median
+84% vs market
20192024
Equity ratio
48.5%
This company
38.2%
Market median
+27% vs market
20192024
Return on equity
77.0%
This company
18.4%
Market median
+318% vs market
20192024
Net profit margin
22.6%
This company
8.1%
Market median
+179% vs market
20192024
Asset turnover
1.65×
This company
1.12×
Market median
+47% vs market
20192024
Debt / equity
1.06×
This company
0.62×
Market median
-71% vs market
20192024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-04-09 – 2019-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Management | Management | 2019 | — | — |
CG Management | Management | 2019 | — | — |
JB Management | Management | 2019 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Symmetri Holding ApS | Company | 33.3% | 33.3% | 2025 |
Glisse Holding ApS | Company | 33.3% | 33.3% | 2025 |
JSFT Holding ApS | Company | 15.0% | 15.0% | 2025 |
| Individual | 10.0% | 10.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
JSFT Holding ApS
Min Osteopat JAC ApS Board members of Min Osteopat JAC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alex Helle-Broe Glistrup | Management | 0 companies |
| Casper Glistrup | Management | 0 companies |
| Jakob Bjerring Langkjær | Management | 0 companies |